Consistent with our inhibitor data, depletion of ABL1 from both lung cancer cell lines harboring ABL1 mutations resulted in a significant reduction in cell viability compared with Beas‐2B cells (Fig 2D–F). Here, ABL1 is linked to lung carcinoma.